Invention Grant
- Patent Title: PARP inhibitors for treating cancer and asthma
-
Application No.: US17272015Application Date: 2019-08-23
-
Publication No.: US12030858B2Publication Date: 2024-07-09
- Inventor: Michael Cohen , Ilsa Kirby
- Applicant: Oregon Health & Science University
- Applicant Address: US OR Portland
- Assignee: Oregon Health & Science University
- Current Assignee: Oregon Health & Science University
- Current Assignee Address: US OR Portland
- Agency: Lee & Hayes, P.C.
- International Application: PCT/US2019/047991 2019.08.23
- International Announcement: WO2020/046753A 2020.03.05
- Date entered country: 2021-02-26
- Main IPC: C07D239/90
- IPC: C07D239/90 ; C07D403/12 ; C07D473/38
Abstract:
Provided are substituted 8-methylquinazolin-4(3H)-one compounds useful as PARP inhibitors for the treatment of cancer and asthma, as well as pharmaceutical compositions comprising them and methods for their synthesis.
Public/Granted literature
- US20210347741A1 PARP INHIBITORS FOR TREATING CANCER AND ASTHMA Public/Granted day:2021-11-11
Information query
